Notice No20190122-30Notice Date22 Jan 2019
CategoryCompany relatedSegmentEquity
SubjectClarifications received from the companies

The Exchange has observed significant price/volume movement in following scrip/s in the recent past. The Exchange in order to ensure that trading member/investors have latest relevant information had written to the following companies. Reply received from them is attached herewith.

1. Shanti Educational Initiatives Ltd (Security Code: 539921)
2. Parenteral Drugs India Ltd (Security Code: 524689)
3. Trejhara Solutions Ltd (Security Code: 542233)

Further, reply from the following companies are awaited:

4. KSL & Industries Ltd (Security Code: 530149)

5. Samrat Pharmachem Ltd (Security Code: 530125)

For & On behalf of BSE Ltd


Yogendra Daxini

Jeevan Noronha

Assistant General Manager

Senior Manager



January 21st, 2019

Shanti Educational Initiatives Ltd_Reply.pdf
Trejhara Solutions Ltd_Reply.pdf
Parenteral Drugs India Ltd_Reply.pdf